Cns Pharmaceuticals Inc (United States) is listed on the Nasdaq and has a market capitalization of $27.83 million, with shareholders equity totaling $18.20 million.
The company employs approximately 8 people and operates in the Other sector, within the Others industry.
Over the past 12 months, Cns Pharmaceuticals Inc reported $- in revenue, generating net income of $-16.70 million.
Key financial metrics include a P/E ratio of -1.67, a price-to-book (P/B) ratio of 1.53, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker CNSP.